Development of an Individualized Immune Prognostic Signature for Clear Cell Renal Cell Carcinoma through the Identification of Differential Immune Genes

Table 3

Clinical features of the low- and high-risk groups in the E-MTAB-1980 cohort.

Clinical parameters		Total	High risk	Low risk	value
		101	50	61
Sex	Female	24	12	12	1
	Male	77	38	39
Age	≤65	57	35	22	0.01168567
	>65	44	15	29
pT	pT1	68	32	36	0.6215551
	pT2-4	33	18	15
N	N0	94	45	49	0.4175018
	N1-2	7	5	2
M	M0	89	43	46	0.7307897
	M1	12	7	5
Fuhrman grade	1 + 2	72	35	37	0.9594934
	3 + 4	27	14	13
	Undetermined	2	1	1

pT, pathological tumor; M, metastasis; N, lymph nodes. values were obtained by Fisher’s test.